4.4 Article

Pharmacoeconomic Impact of Different Regimens to Prevent Cytomegalovirus Infection in Renal Transplant Recipients

Related references

Note: Only part of the references are listed.
Review Infectious Diseases

Cytomegalovirus-associated renal allograft rejection: new challenges for antiviral preventive strategies

Tomas Reischig

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2010)

Article Surgery

Cytomegalovirus in Solid Organ Transplant Recipients

A. Humar et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2009)

Article Urology & Nephrology

Six-Month Prophylaxis Is Cost Effective in Transplant Patients at High Risk for Cytomegalovirus Infection

Fu L. Luan et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)

Review Medicine, General & Internal

Medical progress: Infection in solid-organ transplant recipients

Jay A. Fishman

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Immunology

The economic value of valacyclovir prophylaxis in transplantation

JP Squifflet et al.

JOURNAL OF INFECTIOUS DISEASES (2002)